Skip to main content
Conferences and Meetings Special-Interest Sessions

Special-Interest Sessions

Short name: 2025 Annual Meeting - Invited Program_Special-Interest Sessions
Course start date: 02/17/2026

Sections

General
0 activities

Promoting Language Equity in Care and Research - 12/6/2025
116829A Khan
Leveraging Genetic Diversity in Preclinical Discovery to Guide Precision Medicine
116849A Boehm Jr
116849A de Smith
116849A Machlus
Leveraging Real-World Data in Sickle Cell Disease to Identify and Study Specific Cohorts of Interest
116392A Andemariam
116392A Kanter
116392A Lebensburger
116392A Steinert
Impact of Geography on Care - 12/6/2025
Grassroots Network Lunch
116549A Scott
Blood Presents: How to get Published in a Peer Review Journal
117061A Roberts
From Precision Medicine to Personalized Care: Meeting Patients Where They Are - 12/6/2025
116835A Nemecek
ASH Clinical Practice Guidelines on Hydroxyurea for Sickle Cell Disease
116490A Hankins
116490A Hildenbrand
116490A Reid
Breaking Financial Barriers to Care Through Affordable Innovation - 12/6/2025
116831A Gomez-De Leon Jr
ASH Clinical Practice Guidelines on Myelofibrosis
116489A Hunter
116489A Szuber
116489A Tremblay
ASH Clinical Practice Guidelines on Diagnosis of Iron Deficiency with and without Anemia
116492A Akpan
116492A Sholzberg
116492A Van Doren
Joint Session: Advancing Hematology Through Artificial Intelligence
116846A Wang
116850A Loghavi
116850A McWeeney
116850A Singh
Classical Hematology Advancement Mentorship Program (CHAMP)
From Precision Medicine to Personalized Care: Meeting Patients Where They Are - 12/7/2025
117458A Nemecek
Leveraging Real-World Data in Multiple Myeloma for Regulatory Purposes
116391A Akhtar
116391A Gormley
116391A Kumar
116391A Laane
116391A Sen
116391A Usmani
How Can Community-Based and Academic Hematologists Foster Clinical Trial Participation as Part of Patient Care?
116396A Burke
116396A Dennstaedt
116396A Feige
116396A Keefer
116396A Seremetis
116396A Tunji-Ajayi
116396A Valentino
To, Through and Thereafter: Guiding Sickle Cell Disease Patients Considering Gene Therapy
Updated ASH Clinical Practice Guidelines on Acute Myeloid Leukemia (AML) in Older Adults
116491A Baer
116491A Loh
116491A Malcovati
Breaking Barriers in Blood Cancer: Transforming Access and Outcomes Across Populations - 12/7/2025
116832A Bhatnagar
Blood Advances Presents: How to Peer Review a Scientific Paper
117544A Weyrich
ASH Clinicians in Practice Lunch: Access to Critical Drugs: The Causes, Costs, and Campaigns
116390A Boring
116390A Mackler
116390A Roades
Online Hematology Curriculum/Podcast
116385A Mistry
A Holistic Approach: The Sickle Cell Foundation of Georgia, Inc. & The Sickle Cell Sanctuary - 12/7/2025
117455A McGee
Promoting Language Equity in Care and Research - 12/7/2025
117461A Khan
ASH Clinical Practice Guidelines on Aplastic Anemia
116479A Groarke
116479A Kulasekararaj
116479A Shimano
Updated ASH Clinical Practice Guidelines on Immune Thrombocytopenia (ITP) in Adults
116486A Arnold
116486A Audia
116486A Masias
A Holistic Approach: The Sickle Cell Foundation of Georgia, Inc. & The Sickle Cell Sanctuary - 12/8/2025
116833A McGee
Impact of Geography on Care - 12/8/2025
ASH-FDA Joint Symposium on Newly Approved Therapies I
Breaking Barriers in Blood Cancer: Transforming Access and Outcomes Across Populations - 12/8/2025
117456A Bhatnagar
Innovative Teaching Approaches for Adult Learning
117748A Ellis
Breaking Financial Barriers to Care Through Affordable Innovation - 12/8/2025
117457A Gomez-De Leon Jr
ASH-FDA Joint Symposium on Newly Approved Therapies II
ASH’s SCD Initiative: 10 Years of Progress and a Look to the Future of Sickle Cell Disease Research and Care
116847A Chunda-Liyoka
116847A DeBaun
116847A Liem
116847A Niss
116847A Thompson

Mediasite Content Mediasite Content
34
File File
65